Collectively, a better knowledge of the mechanisms by which circadian clock function can be compromised will lead to novel therapeutic interventions for T2D, obesity, and other metabolic disorders arising from circadian disruption. The gene discussed is CLOCK; the disease is type 2 diabetes mellitus.